Kiromic BioPharma Inc

NASDAQ:KRBP   3:59:51 PM EDT
2.32
+0.40 (+20.83%)
5:04:02 PM EDT: $2.21 -0.11 (-4.74%)
Products, Strategic Combinations, Regulatory

Kiromic Biopharma Inc Announces Strategic Collaboration With Gemelli Teaching Hospital

Published: 10/11/2021 15:52 GMT
Kiromic BioPharma Inc (KRBP) - Kiromic Biopharma Announces Strategic Collaboration With Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic Car-t Clinical Trial Candidate Alexis Iso-1 in Solid Cancers.
Kiromic Biopharma - Strategic Collaboration With Gemelli Teaching Hospital Irccs to Accelerate Analysis of Alexis Iso-1.
Kiromic Biopharma - Anticipate Being Granted a Type a Meeting With FDA by First Half of 2022.
Kiromic Biopharma - Anticipating Being Granted Type a Meeting With FDA by H1 2022 to Discuss Clinical Hold & Clinical Development Path Forward of Ind.
Kiromic Biopharma - Following Type a Meeting, Company Plans to Resubmit Investigational New Drug (ind) Application.